Ubs Asset Management Americas Inc Innoviva, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 140,324 shares of INVA stock, worth $2.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

140,324

Previous 131,449 6.75%

Holding current value

$2.43 Million

Previous $2.54 Million 4.02%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$17.35 - $20.32 $153,981 - $180,340	8,875 Added 6.75%	140,324 $2.43 Million
Q3 2024 Nov 14, 2024	SELL	$16.33 - $20.04 $374,953 - $460,138	-22,961 Reduced 14.87%	131,449 $2.54 Million
Q2 2024 Aug 13, 2024	BUY	$14.4 - $16.4 $1.57 Million - $1.79 Million	109,366 Added 242.8%	154,410 $2.53 Million
Q1 2024 May 15, 2024	SELL	$14.56 - $16.78 $174 - $201	-12 Reduced 0.03%	45,044 $686,000
Q4 2023 Feb 14, 2024	SELL	$12.32 - $16.27 $303,096 - $400,274	-24,602 Reduced 35.32%	45,056 $722,000
Q3 2023 Nov 13, 2023	SELL	$12.37 - $13.89 $62,122 - $69,755	-5,022 Reduced 6.72%	69,658 $904,000
Q1 2023 May 15, 2023	BUY	$10.73 - $13.6 $103,973 - $131,784	9,690 Added 14.91%	74,680 $840,000
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $94,671 - $110,556	8,023 Added 14.08%	64,990 $861,000
Q3 2022 Nov 14, 2022	SELL	$11.61 - $15.22 $123,913 - $162,443	-10,673 Reduced 15.78%	56,967 $661,000
Q2 2022 Aug 12, 2022	BUY	$14.32 - $19.88 $104,278 - $144,766	7,282 Added 12.06%	67,640 $998,000
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $217,855 - $256,332	13,693 Added 29.34%	60,358 $1.04 Million
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $26,759 - $35,324	2,049 Added 4.59%	46,665 $779,000
Q2 2021 Aug 16, 2021	SELL	$11.45 - $13.96 $85,542 - $104,295	-7,471 Reduced 14.34%	44,616 $598,000
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $419,561 - $488,223	-37,935 Reduced 42.14%	52,087 $622,000
Q3 2020 Nov 13, 2020	BUY	$10.33 - $14.49 $249,510 - $349,991	24,154 Added 36.67%	90,022 $940,000
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $163,031 - $216,524	-14,189 Reduced 17.72%	65,868 $920,000
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $62,747 - $117,834	7,737 Added 10.7%	80,057 $941,000
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $83,607 - $116,952	-8,133 Reduced 10.11%	72,320 $1.02 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $215,210 - $311,573	21,414 Added 36.27%	80,453 $847,000
Q2 2019 Aug 15, 2019	BUY	$13.1 - $14.95 $49,596 - $56,600	3,786 Added 6.85%	59,039 $0
Q1 2019 May 14, 2019	SELL	$13.69 - $20.06 $20,726 - $30,370	-1,514 Reduced 2.67%	55,253 $0
Q4 2018 Feb 13, 2019	BUY	$13.96 - $18.26 $155,514 - $203,416	11,140 Added 24.42%	56,767 $990,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.99 $113,160 - $139,318	8,200 Added 21.91%	45,627 $0
Q4 2017 Feb 09, 2018	BUY	$11.73 - $14.75 $24,468 - $30,768	2,086 Added 5.9%	37,427 $0
Q3 2017 Nov 13, 2017	BUY	$12.06 - $14.12 $426,212 - $499,014	35,341	35,341 $0

Others Institutions Holding INVA

# of Institutions

243

Shares Held

77.7M

Call Options Held

52.8K

Put Options Held

800

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.21B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Innoviva, Inc. Transaction History